2016 International Congress Archives - Page 31 of 207

12:00pm-1:30pm: May early introduction of dopaminergic agonists improve simptoms after ischemic stroke? The interim report

J. Kobal, Z. Melik, K. Cankar (Ljubljana, Slovenia)

Neuropharmacology · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Medication use patterns vary across expert Parkinson’s disease clinics

P. Schmidt, F. Cubillos, T. Simuni, C. Marras, T. Davis, E.C. Nelson (Miami, FL, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Medicinal cannabis for Parkinson’s disease: A survey of practices, beliefs, and attitudes among providers at NPF centers of excellence

D. Bega, T. Simuni, M.S. Okun, P. Schmidt (Chicago, IL, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Mental simulation of whole-body movements in patients with isolated cervical dystonia

M. Esposito, C. Vitale, F. Falco, S. Corvino, R. Allocca, S. Peluso, G. Santangelo, M. Conson (Naples, Italy)

Dystonia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Mind the gap: Temporal discrimination and cervical dystonia

A. Sadnicka, C. Daum, C. Cordivari, K.P. Bhatia, J.C. Rothwell, S. Manohar, M.J. Edwards (London, United Kingdom)

Dystonia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Minimizing levodopa titration period for Parkinson’s disease (PD)

I. Thomas, M. Alam, D. Nyholm, M. Senek, J. Westin (Falun, Sweden)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Mobile decision support system for nurse managment of deep brain stimulation

G. Duffley, D. Martinez, J. Krueger, B. Lutz, M.S. Okun, C.R. Butson (Salt Lake City, UT, USA)

Parkinsons's Disease: Clinical Trials I

12:00pm-1:30pm: Motor fluctuations in relation to plasma concentrations following a single-dose of levodopa/carbidopa microtablets in advanced Parkinson’s disease

M. Senek, H. Askmark, S.M. Aquilonius, F. Bergquist, R. Constantinescu, A. Ericsson, S. Lycke, A. Medvedev, M. Memedi, F. Ohlsson, J. Spira, J. Westin, D. Nyholm (Uppsala, Sweden)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Motor phenotype classification in moderate to advanced PD: Data from the BioFIND study

L. Luo, H.F. Andrews, J.G. Goldman, R.N. Alcalay, T. Xie, P. Tuite, C. Henchcliffe, P. Hogarth, A. Amara, S. Frank, A. Rudolph, C. Casaceli, K. Gwinn, M. Sutherland, C. Kopil, L. Vincent, M. Frasier, U.J. Kang (New York, NY, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Motor variability and learning indices in DYT1 dystonia

A. Sadnicka, A. Stevenson, J.C. Rothwell, K.P. Bhatia, J. Galea, M.J. Edwards (London, United Kingdom)

Dystonia · Exhibit Hall located in Hall B, Level 2